Physician

Matthew James Duggan, MD

According to 2025 Medicare claims, Matthew Duggan, MD (NPI: 1780063842) practices ophthalmology in the Asheville, NC market, with the plurality of this provider's patient population coming from Henderson, NC. This provider's primary affiliated billing organization is CAROLINA OPHTHALMOLOGY PA (NPI: 1710936190; TIN: 561310375) and primary practice location at 28732-8623. Duggan is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Duggan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,205 traditional Medicare patients, billed 4,252 HCPCS/CPT codes, and received $359,154 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,624 prescription claims across 824 beneficiaries totaling $340,225 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 21 records totaling $619. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,590 to $359,154. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,459 to $340,225. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$180K$359K2019 Medicare payment: $6,590 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $84,119 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $305,026 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $346,501 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $325,564 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $359,154 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195163$6,590
20204241,097$84,119
20211,0313,450$305,026
20221,0803,844$346,501
20231,1303,904$325,564
20241,2054,252$359,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$204K$408K2015 Drug cost: $1,459 (USD; Tot_Drug_Cst)2016 Drug cost: $7,466 (USD; Tot_Drug_Cst)2017 Drug cost: $7,304 (USD; Tot_Drug_Cst)2018 Drug cost: $7,246 (USD; Tot_Drug_Cst)2019 Drug cost: $86,950 (USD; Tot_Drug_Cst)2020 Drug cost: $320,533 (USD; Tot_Drug_Cst)2021 Drug cost: $230,053 (USD; Tot_Drug_Cst)2022 Drug cost: $388,703 (USD; Tot_Drug_Cst)2023 Drug cost: $408,162 (USD; Tot_Drug_Cst)2024 Drug cost: $340,225 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152032$1,459
201666135$7,466
20172663$7,304
201847107$7,246
2019462944$86,950
20209163,157$320,533
20216892,356$230,053
20226993,187$388,703
20237393,426$408,162
20248243,624$340,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more814955$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more402596$55
92083Exam of visual field with extended testing281305$41
92136Measurement of corneal curvature and depth of eye243373$27
92133Imaging of optic nerve504523$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine291,950$39,819
RhopressaNetarsudil Mesylate713,462$37,644
LumiganBimatoprost533,672$31,433
ProlensaBromfenac Sodium823,388$28,028
CombiganBrimonidine Tartrate/Timolol573,327$25,300

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$619Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew James Duggan, MD?

Tedicare shows public-source Medicare data for Matthew James Duggan, MD (NPI 1780063842), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew James Duggan, MD have ACO affiliation data?

Matthew James Duggan, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Matthew James Duggan, MD?

Matthew James Duggan, MD is linked to CAROLINA OPHTHALMOLOGY PA (billing NPI 1710936190) in the available physician profile data.

Does Matthew James Duggan, MD have Open Payments data?

Matthew James Duggan, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.